SI
Sofinnova Investments Portfolio holdings
AUM
$2.32B
1-Year Est. Return
101.65%
This Fund
S&P 500
1 Year Est. Return
+101.65%
AUM
$2.32B
AUM Growth
+$689M
(+42%)
Holding
70
Top Buys
| 1 | +$72.8M | |
| 2 | +$70.9M | |
| 3 | +$59M | |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$56.9M |
| 5 |
AbbVie
ABBV
|
+$38M |
Top Sells
| 1 | +$139M | |
| 2 | +$55.6M | |
| 3 | +$53.2M | |
| 4 |
Roivant Sciences
ROIV
|
+$47.6M |
| 5 |
DexCom
DXCM
|
+$26M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$27B
| $355M | 15.31% |
1,550,280
|
|
||
|
2
Jazz Pharmaceuticals
JAZZ
$11.1B
| $163M | 7.04% |
959,860
+371,032
|
|
||
3
AstraZeneca
AZN
$299B
| $150M | 6.47% |
1,632,334
+808,401
|
|
||
4
Vera Therapeutics
VERA
$2.94B
| $141M | 6.1% |
2,793,987
|
|
||
5
Bristol-Myers Squibb
BMY
$120B
| $81.6M | 3.52% |
+1,512,994
|
|
||
6
United Therapeutics
UTHR
$23.4B
| $76.8M | 3.31% |
157,641
-32,985
|
|
||
7
Vertex Pharmaceuticals
VRTX
$121B
| $74.6M | 3.22% |
164,594
+46,719
|
|
||
|
8
AbbVie
ABBV
$398B
| $72.6M | 3.13% |
317,783
+166,817
|
|
||
9
Intuitive Surgical
ISRG
$170B
| $71.9M | 3.1% |
126,968
+16,072
|
|
||
10
Cogent Biosciences
COGT
$5.73B
| $70.1M | 3.02% |
1,973,625
-154,316
|
|
||
11
Eli Lilly
LLY
$873B
| $66.3M | 2.86% |
+61,652
|
|
||
|
RAPP
12
Rapport Therapeutics
RAPP
$1.37B
| $57.8M | 2.49% |
1,904,408
-43,171
|
|
||
13
BridgeBio Pharma
BBIO
$13.2B
| $55.1M | 2.38% |
720,448
-111,399
|
|
||
|
RNAM
14
DELISTED
Avidity Biosciences
RNAM
| $53.7M | 2.32% |
745,116
-130,809
|
|
||
15
Dyne Therapeutics
DYN
$2.98B
| $44.1M | 1.9% |
2,254,161
+1,268,333
|
|
||
16
BioMarin Pharmaceuticals
BMRN
$11.4B
| $41.4M | 1.79% |
+697,133
|
|
||
17
Apogee Therapeutics
APGE
$5.06B
| $40.4M | 1.74% |
534,845
-30,572
|
|
||
|
CDTX
18
DELISTED
Cidara Therapeutics
CDTX
| $39.8M | 1.72% |
180,265
+126,068
|
|
||
19
Praxis Precision Medicines
PRAX
$8.45B
| $37.1M | 1.6% |
125,722
-47,111
|
|
||
20
Immatics
IMTX
$1.26B
| $36.1M | 1.56% |
3,435,542
+1,207,705
|
|
||
21
Inhibrx
INBX
$1.01B
| $35.9M | 1.55% |
454,657
+14,565
|
|
||
22
Immunome
IMNM
$2.32B
| $34.8M | 1.5% |
1,618,477
+1,182,426
|
|
||
23
ArriVent BioPharma
AVBP
$1.06B
| $34.1M | 1.47% |
1,696,752
|
|
||
24
Glaukos
GKOS
$5.68B
| $32.5M | 1.4% |
288,128
-24,866
|
|
||
25
IDEAYA Biosciences
IDYA
$2.88B
| $30.6M | 1.32% |
885,121
-37,574
|
|